|
KTELC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.53680000003487E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.07620000000275E-05 |
| Normal-vs-Stage2 |
1.201800E-04 |
| Normal-vs-Stage3 |
5.5619000516316E-09 |
| Normal-vs-Stage4 |
2.82000000018101E-07 |
| Stage1-vs-Stage2 |
7.231600E-01 |
| Stage1-vs-Stage3 |
2.742700E-03 |
| Stage1-vs-Stage4 |
2.285500E-02 |
| Stage2-vs-Stage3 |
9.051600E-02 |
| Stage2-vs-Stage4 |
1.086160E-01 |
| Stage3-vs-Stage4 |
9.435600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.38370000002386E-06 |
| Normal-vs-AfricanAmerican |
4.419800E-03 |
| Normal-vs-Asian |
1.81605999999279E-05 |
| Caucasian-vs-AfricanAmerican |
7.025600E-01 |
| Caucasian-vs-Asian |
8.837200E-01 |
| AfricanAmerican-vs-Asian |
6.493000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.82290000000962E-07 |
| Normal-vs-Female |
1.76649999994449E-06 |
| Male-vs-Female |
9.809200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.62490000000082E-05 |
| Normal-vs-Age(41-60Yrs) |
3.37290000040902E-07 |
| Normal-vs-Age(61-80Yrs) |
1.64989999995591E-06 |
| Normal-vs-Age(81-100Yrs) |
2.759400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.730000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.611610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.934000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.489600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.720000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.984600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.261250E-03 |
| Classical-VS-Follicular |
8.690400E-02 |
| Classical-VS-Other |
3.206200E-01 |
| Classical-VS-Normal |
8.36400000000515E-05 |
| Tall-VS-Follicular |
5.166000E-02 |
| Tall-VS-Other |
5.045400E-01 |
| Tall-VS-Normal |
5.83239999629726E-08 |
| Follicular-VS-Other |
6.802000E-01 |
| Follicular-VS-Normal |
3.41090000000044E-06 |
| Other-VS-Normal |
2.002300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.09829999994648E-06 |
| Normal-vs-N1 |
3.05649999976509E-07 |
| N0-vs-N1 |
2.402400E-01 |
|
|
